FIELD: medicine.
SUBSTANCE: invention concerns medicine and claims method of acute and/or chronic neuralgic disorder or disturbance treatment and/or prevention, pharmaceutical composition including acetylcholinesterase inhibitor (AChE enzyme inhibitor) and metabotropic glutamate receptor 2 antagonist (mGluR2 receptor antagonist), application of AChE enzyme inhibitor and mGluR2 receptor antagonist in obtaining medicine, and combinations including AChE enzyme inhibitor and mGluR2 receptor antagonist.
EFFECT: synergetic effect of AChE enzyme inhibitor and mGluR2 receptor antagonist combination for treatment of acute and chronic neuralgic disorders or disturbances.
13 cl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF DIHYDROBENZODIAZEPIN-2-ONE FOR TREATMENT OF NEUROLOGICAL DISORDERS | 2003 |
|
RU2315764C2 |
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS I mGluR2 ANTAGONISTS | 2002 |
|
RU2270197C2 |
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS ANTAGONISTS OF MGLUR2 II | 2002 |
|
RU2263112C2 |
6,7-DIHYDROPYRAZOLO[1,5-α]PYRAZIN-4(5H)-ONE COMPOUNDS AND USE THEREOF AS NEGATIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS | 2015 |
|
RU2696135C2 |
PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS | 2006 |
|
RU2411237C2 |
PHARMACEUTICAL COMPOSITION CONTAINING BENZODIAZEPINE DERIVATIVES AND RSV FUSION PROTEIN INHIBITOR | 2005 |
|
RU2388476C2 |
NOVEL PYRAZOLE DERIVATIVES | 2014 |
|
RU2682247C2 |
BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2496775C2 |
DERIVATIVES OF BENZODIAZEPINE, MEDICINAL AGENT COMPRISING THEREOF AND METHOD FOR THEIR PREPARING | 2000 |
|
RU2257382C2 |
AMINOSUBSTITUTED DIARYL [a, d] CYCLOHEPTANE ANALOGUES AS MUSCARINIC AGONISTS AND METHOD OF TREATING PSYCHONEUROLOGICAL DISORDERS | 2004 |
|
RU2394030C2 |
Authors
Dates
2009-06-10—Published
2004-07-17—Filed